Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. - Wikidata - awgldk - TriplyDB

Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.

Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.

http://www.wikidata.org/entity/Q37431348

about

Caveolae and Caveolin-1 Integrate Reverse Cholesterol Transport and Inflammation in Atherosclerosis Structural Insights into High Density Lipoprotein: Old Models and New Facts Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins 3-nitrotyrosine modified proteins in atherosclerosis Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein Proteomics of citrullination in cardiovascular disease HDL-apoA-I exchange: rapid detection and association with atherosclerosis A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation.Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteins Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases.Friend Turns Foe: Transformation of Anti-Inflammatory HDL to Proinflammatory HDL during Acute-Phase Response Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis.Neutrophils Turn Plasma Proteins into Weapons against HIV-1.Myeloperoxidase in human neutrophil host defence.IL-1Β enriched monocytes mount massive IL-6 responses to common inflammatory triggers among chronically HIV-1 infected adults on stable anti-retroviral therapy at risk for cardiovascular disease Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes A biochemical fluorometric method for assessing the oxidative properties of HDL.Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain.Crosstalk between reverse cholesterol transport and innate immunity.Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity.Reactive Oxygen Species, SUMOylation, and Endothelial Inflammation Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F.HDL and endothelial protection.Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes.Untrained young men have dysfunctional HDL compared with strength-trained men irrespective of body weight status High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease

P2860

Q26752101-5E61285B-C3AF-4B60-8DE5-F4B8AD3C3E35 Q26770434-067A84EF-98C0-4744-B720-150516E31531 Q26774903-46109ECF-26D5-4948-9089-934B7BE40302 Q26996600-2E6AE258-2972-41BC-A221-17EC6A804719 Q27026686-4589B542-207B-4DB0-BB75-4FA3CE96B50A Q28074264-8214C373-DAE9-491C-B932-E9B41E5996A9 Q28083260-8E08402A-DD11-49F9-8990-8D43D0E2CE1D Q28083619-2AB5F982-FD3D-4EE8-9682-A4AB2BAC2220 Q28242377-0B77452A-E21D-4B11-97C7-3C38DE6F38D5 Q28535779-055920BD-4DBD-42FF-8B3A-EFAF150921E3 Q28544713-14C383AF-167F-43C3-B130-CD6087DA73B2 Q30240734-5ADEBB3A-503D-4CD8-B84A-ADD683D90E48 Q30251918-748E1B74-2C6E-4003-965F-F2B4F67D69B5 Q33675617-A5966B36-79E7-4943-A0E0-21450D609121 Q33688005-01AA5C79-CC60-432D-BFD3-C4F0C3155B5A Q33729198-73EC15E0-0BDF-4DC9-BF8B-82D459DCFCD6 Q34022219-31E2616C-C578-4F73-B9FE-5C7E7848213A Q34291776-24B609AC-D87B-4F9F-A966-6F34170DDB74 Q34317326-3956FE1E-7E44-489F-97F3-0AC5BE19F78A Q34730934-D009327E-B96D-4CD4-85AC-AEF340E2DE94 Q34731730-E1BD8177-46C4-42DB-B849-673D7582391F Q34804975-EB7BA844-EEF8-4F1D-BC04-B5CDC9E536A8 Q34994685-716924CF-C271-4E84-8787-F6F0A2DE659E Q35005668-95B7B7BF-5BFD-417A-8507-1A4921643DE7 Q35067364-D97F8C04-3862-4175-B4DB-A0149518E3FA Q35120941-30F377A6-4B83-4F42-B4DE-723090FAA15A Q35227165-5D02467B-720A-4D52-B29C-13801CD03DAF Q35562004-EE747C56-7519-47B7-BBF9-B8DB3A5D6137 Q35572369-3CF4D9A1-9BCC-445C-A541-3603F5674AD7 Q35909357-3A003DB3-F17A-4806-A67B-9F754C336DC3 Q35917056-DB87B8AA-53D6-4D53-A5EC-0C11F3833DC5 Q36130121-9BCC0C95-CBC5-4518-90C7-FC3C09532983 Q36237663-05184E22-2B63-4049-91F1-BE20FE3FF475 Q36520295-4A4D9CF0-AC69-47E3-B5D8-27DC67FD79DF Q36929420-1781FFC3-97A5-42CA-94BF-1C0F66153C75 Q37045120-EAAF6E0B-28BB-491C-B5EB-92FD2C86CC15 Q37123887-32C379D0-1435-4049-B112-FA04009E064D Q37211868-4882F5DB-ABDB-4B5B-80E7-FEA0041B1985 Q37235070-91221C22-A24B-4BE7-9508-7820BFCC26C6 Q37305341-3D4DA4AA-29DF-41DA-ACFD-DBD33591F62B

P2860

Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.

http://www.wikidata.org/entity/Q37431348

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Modification of high density l ...... s a pro-inflammatory particle.

@en

Modification of high density l ...... s a pro-inflammatory particle.

@nl

type

label

Modification of high density l ...... s a pro-inflammatory particle.

@en

Modification of high density l ...... s a pro-inflammatory particle.

@nl

prefLabel

Modification of high density l ...... s a pro-inflammatory particle.

@en

Modification of high density l ...... s a pro-inflammatory particle.

@nl

P1433

Q37431348-1745B3D1-74BC-4FA4-AF19-D3310BCB9200

P1476

Q37431348-97A9A1F0-41EA-4B8A-929C-419EBBA39702

P2093

Q37431348-332B832B-92E3-4B84-926C-0F69B14C1AE2

Q37431348-68DED96E-FBBB-4A42-BB6E-469C75FA3E45

Q37431348-831D1554-36D5-445F-A473-5780209ECDB7

Q37431348-AD583778-6A21-4936-A359-E6CC8F9ED363

Q37431348-CAC4F963-B647-40D1-BBB1-AD4C4AE59C10

Q37431348-FF8782ED-D348-4DDD-ACD5-F4B715D1BDDE

P2860

Q37431348-005C20C9-A6E8-4A93-ADB9-DA911F96E76C

Q37431348-01FCA1CA-3DB0-42F0-A5EF-A32F19C29760

Q37431348-02563CAB-8359-422A-A40F-426014F92DA7

Q37431348-05BCDF31-9701-4E80-962B-79FBAEDC96F0

Q37431348-100A8EA8-4C7D-481E-B5D1-9E3536071313

Q37431348-196867E1-5B18-46B6-990D-E174E4E15A53

Q37431348-252063E8-E23A-4413-A793-B484FAFB9ADC

Q37431348-283D10FE-10A3-4AFA-93ED-90194E0E9CFB

Q37431348-2F4E1AB8-9180-4D58-9254-E40F9FF52D0F

Q37431348-2FCADB55-C8BE-430A-8FC4-572EDC462D6D

P304

Q37431348-9FAAA1A7-933C-4F9C-86EC-B142F9C5301A

P31

Q37431348-9E713416-48A8-49B5-9E5E-8F75C342FEB3

P356

Q37431348-A212C94D-980C-4B4E-91F7-6171B394D02B

P407

Q37431348-5124CCE7-0313-4E5B-9D11-AFB66EF7B2D5

P433

Q37431348-C7B89B87-3FCE-42CA-83EF-3D169A0757A5

P478

Q37431348-4C87E7A4-11B5-4A43-9D92-0FD36F773000

P577

Q37431348-0024CAEA-A62B-4E16-973F-5C6E4A78B26C

P5875

Q37431348-BEB9734D-1C0C-427B-90DB-E6EBE0338226

P698

Q37431348-123A182C-34D1-42EE-BE98-02F4D40E087F

P921

Q37431348-0A9C9740-7EBF-4631-93C5-D094664A792D

Q37431348-870F5F7E-541D-4178-A6C2-DE3189415514

P932

Q37431348-AF18F507-05EE-40A5-BB0A-C89A26BBC70C

P356

JBC.M109.047605

P1433

Journal of Biological Chemistry

P1476

Modification of high density l ...... s a pro-inflammatory particle.

@en

P2093

Arundhati Undurti

http://www.w3.org/2001/XMLSchema#string

Jonathan D Smith

http://www.w3.org/2001/XMLSchema#string

Joseph A DiDonato

http://www.w3.org/2001/XMLSchema#string

Joseph A Lupica

http://www.w3.org/2001/XMLSchema#string

Stanley L Hazen

http://www.w3.org/2001/XMLSchema#string

Ying Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

Nitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling

HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production

Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36

Protein carbamylation links inflammation, smoking, uremia and atherogenesis.

Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1).

P304

30825-30835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M109.047605

http://www.w3.org/2001/XMLSchema#string

P407

P433

45

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26786016

http://www.w3.org/2001/XMLSchema#string

P698

19726691

http://www.w3.org/2001/XMLSchema#string

P921

P932

2781481

http://www.w3.org/2001/XMLSchema#string